School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.
Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK, Canada.
EMBO J. 2023 May 2;42(9):e113490. doi: 10.15252/embj.2023113490. Epub 2023 Mar 15.
Mycobacterium tuberculosis (Mtb) infection is initiated by inhalation of bacteria into lung alveoli, where they are phagocytosed by resident macrophages. Intracellular Mtb replication induces the death of the infected macrophages and the release of bacterial aggregates. Here, we show that these aggregates can evade phagocytosis by killing macrophages in a contact-dependent but uptake-independent manner. We use time-lapse fluorescence microscopy to show that contact with extracellular Mtb aggregates triggers macrophage plasma membrane perturbation, cytosolic calcium accumulation, and pyroptotic cell death. These effects depend on the Mtb ESX-1 secretion system, however, this system alone cannot induce calcium accumulation and macrophage death in the absence of the Mtb surface-exposed lipid phthiocerol dimycocerosate. Unexpectedly, we found that blocking ESX-1-mediated secretion of the EsxA/EsxB virulence factors does not eliminate the uptake-independent killing of macrophages and that the 50-kDa isoform of the ESX-1-secreted protein EspB can mediate killing in the absence of EsxA/EsxB secretion. Treatment with an ESX-1 inhibitor reduces uptake-independent killing of macrophages by Mtb aggregates, suggesting that novel therapies targeting this anti-phagocytic mechanism could prevent the propagation of extracellular bacteria within the lung.
结核分枝杆菌(Mtb)感染是由细菌吸入肺肺泡引发的,在肺泡中被常驻巨噬细胞吞噬。细胞内 Mtb 复制诱导受感染的巨噬细胞死亡,并释放细菌聚集体。在这里,我们表明这些聚集体可以通过一种不依赖摄取但依赖接触的方式杀死巨噬细胞,从而逃避吞噬作用。我们使用延时荧光显微镜显示,与细胞外 Mtb 聚集体接触会触发巨噬细胞质膜扰动、细胞溶质钙积累和细胞焦亡。这些效应依赖于 Mtb ESX-1 分泌系统,但在没有 Mtb 表面暴露脂质双分枝酸二酰基甘油的情况下,该系统本身不能诱导钙积累和巨噬细胞死亡。出乎意料的是,我们发现,阻断 ESX-1 介导的 EsxA/EsxB 毒力因子的分泌并不能消除巨噬细胞的非摄取依赖性杀伤,并且 ESX-1 分泌的 50kDa 同工型 EspB 蛋白可以在没有 EsxA/EsxB 分泌的情况下介导杀伤。ESX-1 抑制剂的处理可降低 Mtb 聚集体对非摄取依赖性杀伤巨噬细胞的作用,表明针对这种抗吞噬机制的新型疗法可能有助于防止肺内细胞外细菌的传播。